Mr Wonderful's DeFi Winner
Kevin O'Leary picks one stock from each sector. This is his pick for DeFi.
Read more.

OCC Insider Trading (Orthocell)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$4,860.00
Insider Selling (Last 12 Months): A$208,495.77

Orthocell Insider Trading History Chart

This chart shows the insider buying and selling history at Orthocell by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Orthocell Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for OCC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
This Tech Stock Is Disruptive
This stock is ready to go vertical! It could win tech innovation of the year.
Learn more

Orthocell Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/23/2021Paul AndersonInsiderSell435,273A$0.48A$208,495.77
4/6/2021Lars LidgrenInsiderBuy9,000A$0.54A$4,860.00
7/11/2019Matthew (Matt) CallahanInsiderIssued21,053A$0.48A$10,000.18
6/6/2019Stewart WasherInsiderIssued24,366A$0.51A$12,499.76
See Full Table
Insider Trading at Orthocell?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Orthocell and related companies.

SEC Filings (Institutional Ownership Changes) for Orthocell (ASX:OCC)

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair and regeneration of human tendon, bone, nerve, and cartilage defects in Australia. The company's principal products include CelGro, a naturally derived collagen medical device for soft tissue repair that is under clinical trials for use as an augment to the surgical repair of tendons, peripheral nerves, bones, and articular cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation for the treatment of symptomatic defects of the articulating cartilage of the joints, primarily in the knee and ankle. Orthocell Limited was founded in 2006 and is based in Murdoch, Australia.
Read More on Orthocell

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

669,530 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Orthocell?

Orthocell's top insider investors include:
  1. Lars Lidgren (Insider)
  2. Paul Anderson (Insider)
Mr Wonderful's DeFi Winner
Kevin O'Leary picks one stock from each sector. This is his pick for DeFi.
Read more.